Hudock, Inc. Amarin Corp Plcuk Transaction History

Hudock, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$1.09 - $1.67 $436 - $668	-400 Reduced 30.98%	891 $0
Q2 2020 Aug 11, 2020	SELL	$4.78 - $8.26 $760 - $1,313	-159 Reduced 10.97%	1,291 $8,000
Q4 2019 Jan 21, 2020	SELL	$13.94 - $24.12 $153 - $265	-11 Reduced 0.75%	1,450 $31,000
Q3 2019 Oct 31, 2019	BUY	$13.89 - $23.16 $13,473 - $22,465	970 Added 197.56%	1,461 $22,000
Q2 2019 Jul 30, 2019	BUY	$16.27 - $20.51 $3,254 - $4,102	200 Added 68.73%	491 $9,000
Q1 2019 Apr 23, 2019	BUY	$12.61 - $22.33 $1,147 - $2,032	91 Added 45.5%	291 $6,000
Q4 2018 Jan 29, 2019	BUY	$12.41 - $22.98 $2,482 - $4,596	200 New	200 $2,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.